Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Pasqualucci

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
British Journal of Haematology|March 1, 1996
Anti-CD30 (BER=H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID miceA Terenzi, A Bolognesi, L Pasqualucci, et al.
The American Journal of Pathology|December 1, 1996
Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissuesM Gambacorta, L Flenghi, M Fagioli, et al.
Blood|November 14, 1997
Immunocytochemical diagnosis of acute promyelocytic leukemia (M3) with the monoclonal antibody PG-M3 (anti-PML)B Falini, L Flenghi, M Fagioli, et al.
Leukemia & Lymphoma|August 28, 1998
BCL-6 in aids-related lymphomas: pathogenetic and histogenetic implicationsG Gaidano, D Capello, A Gloghini, et al.
DNA Sequence : the Journal of DNA Sequencing and Mapping|October 16, 1999
Analysis of a 69-kb contiguous genomic sequence at a putative tumor suppressor gene locus on human chromosome 6q27X Y Qu, R S Hauptschein, A Rzhetsky, et al.
Blood|January 15, 1996
Distinctive expression pattern of the BCL-6 protein in nodular lymphocyte predominance Hodgkin's diseaseB Falini, B Bigerna, L Pasqualucci, et al.
The American Journal of Pathology|May 1, 1996
Monoclonal antibodies PG-B6a and PG-B6p recognize, respectively, a highly conserved and a formol-resistant epitope on the human BCL-6 protein amino-terminal regionL Flenghi, B Bigerna, M Fizzotti, et al.
Blood|January 11, 2000
Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasiaD Capello, U Vitolo, L Pasqualucci, et al.
Leukemia|August 30, 2016
Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphomaY Xia, Z Y Xu-Monette, A Tzankov, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
British Journal of Haematology|March 1, 1996
Anti-CD30 (BER=H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID miceA Terenzi, A Bolognesi, L Pasqualucci, et al.
The American Journal of Pathology|December 1, 1996
Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissuesM Gambacorta, L Flenghi, M Fagioli, et al.
Blood|November 14, 1997
Immunocytochemical diagnosis of acute promyelocytic leukemia (M3) with the monoclonal antibody PG-M3 (anti-PML)B Falini, L Flenghi, M Fagioli, et al.
Leukemia & Lymphoma|August 28, 1998
BCL-6 in aids-related lymphomas: pathogenetic and histogenetic implicationsG Gaidano, D Capello, A Gloghini, et al.
DNA Sequence : the Journal of DNA Sequencing and Mapping|October 16, 1999
Analysis of a 69-kb contiguous genomic sequence at a putative tumor suppressor gene locus on human chromosome 6q27X Y Qu, R S Hauptschein, A Rzhetsky, et al.
Blood|January 15, 1996
Distinctive expression pattern of the BCL-6 protein in nodular lymphocyte predominance Hodgkin's diseaseB Falini, B Bigerna, L Pasqualucci, et al.
The American Journal of Pathology|May 1, 1996
Monoclonal antibodies PG-B6a and PG-B6p recognize, respectively, a highly conserved and a formol-resistant epitope on the human BCL-6 protein amino-terminal regionL Flenghi, B Bigerna, M Fizzotti, et al.
Blood|January 11, 2000
Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasiaD Capello, U Vitolo, L Pasqualucci, et al.
Leukemia|August 30, 2016
Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphomaY Xia, Z Y Xu-Monette, A Tzankov, et al.
Pageof 2